Skip to Content

Health

How the Novavax Covid-19 vaccine works

At the headquarters of biotechnology company Novavax, scientists are developing what they hope could soon be another Covid-19 vaccine for the United States and the world. Data from the company’s large-scale Phase 3 clinical trial of the vaccine in the US and Mexico are expected this month, but the timeline depends on how quickly it

Continue Reading

Ongoing trial shows Pfizer Covid-19 vaccine remains highly effective after six months

The ongoing Phase 3 clinical trial of Pfizer/BioNTech’s coronavirus vaccine confirms its protection remains high for at least six months after the second dose, the companies said Thursday. Protection likely lasts even longer than that, vaccine experts say, but they say having data showing good protection six months after people were vaccinated is good news.

Continue Reading

Quality issue at Baltimore vaccine plant delays some of Johnson & Johnson’s vaccine

Drugmaker Johnson & Johnson said Wednesday it had found a quality problem at a Baltimore plant helping manufacture its single-dose coronavirus vaccine under contract. The New York Times reported Wednesday. that workers at Emergent BioSolutions, the Baltimore plant that has been making Johnson & Johnson’s Covid-19 vaccine, accidentally mixed up some of the ingredients, ruining

Continue Reading

Covid-19 led to a global increase in stillbirths, maternal mortality, and depression, review finds

The Covid-19 pandemic had a significant and negative impact on pregnant women and their infants, according to a global review of studies. The review, published Wednesday in the journal the Lancet, found that stillbirths and maternal deaths increased by nearly a third, according to pooled data from 40 studies that covered 17 countries. There was

Continue Reading

Recent data ‘good news’ as hospitalizations for seniors decrease in Missouri

COLUMBIA, Mo. (KMIZ) New research shows that COVID-19 hospitalization rates for Missourians ages 60 or older have decreased since the peak in December 2020, while rates of hospitalization for adults ages 59 or younger have increased. Dave Dillion with the Missouri Hospital Association said older populations have been targeted to receive the vaccine since the rollout began. “Older

Continue Reading